Literature DB >> 23644176

Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection.

Sukumar Pal1, Luis M de la Maza.   

Abstract

To determine the immune components needed for protection of newborn mice against Chlamydia muridarum, animals born to Chlamydia-immunized and to sham-immunized dams were infected intranasally with C. muridarum at 2 post-natal days. T-cells isolated from immunized or sham-immunized adult mice were adoptively transferred to newborn mice at the time of infection. Also, to establish what cytokines are involved in protection, IFN-γ, TNF-α, IL-10, and IL-12 were passively transferred to newborn mice. To assess the Chlamydia burden in the lungs mice were euthanized at 12 post-natal days. When T-cells from immunized adult mice were transferred, mice born to and fed by immunized dams were significantly protected as evidenced by the reduced number of Chlamydia isolated from the lungs compared to mice born to and fed by sham-immunized dams. Transfer of IFN-γ and TNF-α also significantly reduced the number of Chlamydia in the lungs of mice born to immunized dams. Transfer of IL-10 or IL-12 did not result in a significant reduction of Chlamydia. In vitro T-cell proliferation data suggest that neonatal antigen presenting cells can present Chlamydia antigens to adult T-cells. In conclusion, maternal antibodies and Chlamydia specific T-cells or Th1 cytokines are required for protection of neonates against this pathogen.
Copyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chlamydia muridarum; Maternal antibodies; Neonatal immunity; Neonatal mouse model; Passive immunity

Mesh:

Substances:

Year:  2013        PMID: 23644176      PMCID: PMC5058356          DOI: 10.1016/j.micinf.2013.04.010

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  45 in total

Review 1.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 2.  Chlamydia trachomatis infections in neonates and young children.

Authors:  Toni Darville
Journal:  Semin Pediatr Infect Dis       Date:  2005-10

3.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.

Authors:  S Kohl; L S Loo
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine.

Authors:  H S Koren; D B Amos; Y B Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-04-17       Impact factor: 17.586

7.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Authors:  N J Davidson; S A Hudak; R E Lesley; S Menon; M W Leach; D M Rennick
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

9.  Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.

Authors:  R Palacios
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity.

Authors:  Hyun-Hee Lee; Christine M Hoeman; John C Hardaway; F Betul Guloglu; Jason S Ellis; Renu Jain; Rohit Divekar; Danielle M Tartar; Cara L Haymaker; Habib Zaghouani
Journal:  J Exp Med       Date:  2008-09-01       Impact factor: 14.307

View more
  6 in total

1.  Low Vitamin D is Associated With Infections and Proinflammatory Cytokines During Pregnancy.

Authors:  Christine C Akoh; Eva K Pressman; Elizabeth Cooper; Ruth Anne Queenan; Julie Pillittere; Kimberly O O'Brien
Journal:  Reprod Sci       Date:  2017-06-15       Impact factor: 3.060

2.  Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.

Authors:  Sukumar Pal; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates.

Authors:  Gopala Krishna Koundinya Lanka; Jieh-Juen Yu; Siqi Gong; Rishein Gupta; Shamimunisa B Mustafa; Ashlesh K Murthy; Guangming Zhong; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Pathog Dis       Date:  2016-01-10       Impact factor: 3.166

4.  Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.

Authors:  Xiaohua Dong; Yuanjun Liu; Xiaotong Chang; Lei Lei; Guangming Zhong
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

5.  Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung.

Authors:  Yumeng Li; Chuan Wang; Zhenjie Sun; Jian Xiao; Xiaoliang Yan; Yuqing Chen; Jian Yu; Yimou Wu
Journal:  Int J Nanomedicine       Date:  2019-10-08

Review 6.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.